Reckitt Benckiser Group plc (3RB0.DE)

Xetra · Consumer Defensive · Household & Personal Products
€67.28+0.96%As of 2026-11-22 · EUR
Last session low €67.10Last session high €68.00
52-week low €52.0052-week high €75.04
Market cap (USD)
$46.74B
Sector
Consumer Defensive
P/E (TTM)
13.2x
Dividend yield
3.73%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in EUR.

IndicatorValueReading
RSI (14)56.9In the neutral range (30 to 70)
MACD (12, 26, 9)1.35Below its signal line (1.55); histogram -0.20
Bollinger %B (20, 2)57%Inside the bands (62.95 to 70.56)
SMA 2066.75Price is 0.8% above
SMA 5063.03Price is 6.7% above
SMA 20060.27Price is 11.6% above
ATR (20)2.63% of priceAverage true range per day
52-week position66%In the middle of the 52.00 to 75.04 range

About Reckitt Benckiser Group plc

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names.

Insider filings, 90 days4 purchases (about 139K EUR) and no sales.
Latest fiscal yearEnded 2025-12-31: revenue of 14.21B GBP and an operating margin of 24.1%.

Also listed as RKT.L (LSE)

More in Household & Personal Products